Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 4
2023 6
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean falco s (229 results)?
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis.
Spagni G, Vincent A, Sun B, Falso S, Jacobson LW, Devenish S, Evoli A, Damato V. Spagni G, et al. Among authors: falso s. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200313. doi: 10.1212/NXI.0000000000200313. Epub 2024 Sep 9. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39250722 Free PMC article.
Reply to "MuSK-Myasthenia Gravis and Cancer".
Falso S, Iorio R. Falso S, et al. Ann Neurol. 2024 Nov;96(5):1030-1031. doi: 10.1002/ana.27091. Epub 2024 Oct 4. Ann Neurol. 2024. PMID: 39363704 No abstract available.
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
Spagni G, Gastaldi M, Businaro P, Chemkhi Z, Carrozza C, Mascagna G, Falso S, Scaranzin S, Franciotta D, Evoli A, Damato V. Spagni G, et al. Among authors: falso s. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 21;10(1):e200038. doi: 10.1212/NXI.0000000000200038. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36270951 Free PMC article.
Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab.
Damato V, Spagni G, Monte G, Scandiffio L, Cavalcante P, Zampetti N, Fossati M, Falso S, Mantegazza R, Battaglia A, Fattorossi A, Evoli A. Damato V, et al. Among authors: falso s. Neuromuscul Disord. 2023 Mar;33(3):288-294. doi: 10.1016/j.nmd.2023.02.005. Epub 2023 Feb 11. Neuromuscul Disord. 2023. PMID: 36842303 Free PMC article.
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report.
Bianco A, Colò F, Falso S, Russo R, Carlà MM, Minucci A, Cadoni G, Lucchini M, Cicia A, Calabresi P, Mirabella M. Bianco A, et al. Among authors: falso s. J Neurol. 2023 Feb;270(2):614-617. doi: 10.1007/s00415-022-11406-2. Epub 2022 Oct 12. J Neurol. 2023. PMID: 36222903 Free PMC article. No abstract available.
14 results